niacinamide has been researched along with fibrinogen in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Francis, S; Jaraki, O; Loscalzo, J; Stamler, JS; Strauss, WE | 1 |
Bolli, GB; Brunetti, P; Cruciani, G; De Feo, P; Lucidi, P; Monacchia, F; Reboldi, G; Volpi, E | 1 |
Chevalier, S; Daguès, N; Freslon, JL; Guigon, G; Hanton, G; Ledieu, D; Pawlowski, V; Sobry, C | 1 |
Kim, SH; Lee, HJ; Park, SC; Shin, NR; Son, Y | 1 |
4 other study(ies) available for niacinamide and fibrinogen
Article | Year |
---|---|
Antiplatelet effects of a novel antianginal agent, nicorandil.
Topics: Acetylcysteine; Adenosine Diphosphate; Analysis of Variance; Binding Sites; Blood Platelets; Cyclic GMP; Dose-Response Relationship, Drug; Drug Tolerance; Fibrinogen; Guanylate Cyclase; Humans; Niacinamide; Nicorandil; Platelet Aggregation; Platelet Aggregation Inhibitors; Potassium Channels; Radioimmunoassay; Vasodilator Agents | 1994 |
Nicotinamide counteracts alcohol-induced impairment of hepatic protein metabolism in humans.
Topics: Adult; Albumins; Alcohol Drinking; Blood Glucose; Body Mass Index; Drug Interactions; Ethanol; Female; Fibrinogen; Humans; Immunoglobulin G; Insulin; Lactates; Leucine; Liver; Male; NAD; Niacinamide; Oxidation-Reduction; Proteins; Pyruvates | 1997 |
Altered gene expression in rat mesenteric tissue following in vivo exposure to a phosphodiesterase 4 inhibitor.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Azepines; Cluster Analysis; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Fibrinogen; Gene Expression Profiling; Gene Expression Regulation; Inflammation; Interleukins; Male; Mesenteric Arteries; Mesentery; Niacinamide; Oligonucleotide Array Sequence Analysis; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2007 |
Fibrinogen-Like Protein 1 Modulates Sorafenib Resistance in Human Hepatocellular Carcinoma Cells.
Topics: Apoptosis; Autophagy; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Fibrinogen; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Liver Neoplasms; MAP Kinase Signaling System; Niacinamide; Phenylurea Compounds; Signal Transduction; Sorafenib | 2021 |